Janne Tolstrup | Adolescent health | Best Researcher Award

Published on by Global Academic Awards

Prof Janne Tolstrup : Adolescent healthย 

Meet Prof. Janne Schurmann Tolstrup, a distinguished epidemiologist and intervention researcher, born on November 24, 1972 (50 yrs). With a DMSc from the University of Southern Denmark in 2011 and a Ph.D. from the University of Copenhagen in 2006, she has demonstrated unparalleled expertise. Currently, since 2019, she serves as a Professor in Epidemiology and Intervention Research at the University of Southern Denmark. Prof. Tolstrup’s impactful journey includes roles as Snr Director of Epidemiology and Datascience at Novo Nordisk and Professor at the National Institute of Public Health. Her leadership in modern media interventions and extensive research program direction showcases her commitment to advancing public health. ๐ŸŒ๐Ÿ”ฌ

Professional profile:

Scopus profileย 

Orcid profile

Google Scholar

Education:

In 2006, Dr. Janne Schurmann Tolstrup earned her Ph.D. from the University of Copenhagen, marking the beginning of her illustrious academic journey. She furthered her expertise with a Master’s in Human Biology in 2000, showcasing her commitment to in-depth scientific knowledge. Driven by a passion for research management, she completed a course at the Copenhagen Business School in 2008, broadening her skill set. In 2011, her academic pursuits reached new heights as she attained a Doctor of Medical Science (DMSc) degree from the University of Southern Denmark. This diverse educational background reflects her dedication to advancing knowledge in epidemiology and interventions, shaping a remarkable career in the field. ๐ŸŽ“๐Ÿ”ฌ

Employments:

Dr. Janne Schurmann Tolstrup’s impactful career unfolds as a trailblazer in epidemiology and intervention research. Since 2019, she has held the prestigious position of Professor in Epidemiology and Intervention Research at the University of Southern Denmark. Previously, as the Senior Director of Epidemiology and Data Science at Novo Nordisk (2018-2019), she contributed to cutting-edge advancements in the field. Notably, from 2011 to 2016, Dr. Tolstrup led the Work Package of Modern Media Interventions at the Center for Intervention Research in Health Promotion and Disease Prevention. Her extensive leadership roles, including Research Programme Director and work on alcohol interventions, reflect her commitment to advancing public health strategies. ๐ŸŒ๐Ÿ”ฌ

Research Focus:

Prof. Janne Schurmann Tolstrup is a distinguished researcher with a prominent focus on Epidemiology and Intervention Research. Her impactful contributions, as evidenced by numerous published works, reflect a deep commitment to understanding health-related phenomena. In her role as a Professor at the University of Southern Denmark since 2019, she continues to delve into crucial aspects of public health. Her extensive research spans diverse topics, including the association between alcohol and cardiovascular disease, sitting time and diabetes risk, and risk prediction for cardiovascular disease. Prof. Tolstrup’s work demonstrates a dedication to advancing scientific knowledge in epidemiology, shaping a healthier future for communities. ๐ŸŒ๐Ÿ”ฌ

Publication Top Notes:
  1. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
    • ๐Ÿ“… 2014
    • ๐Ÿ“ˆ Cited by 776
  2. Total sitting time and the risk of incident diabetes in Danish adults (the DANHES cohort) over 5 years: a prospective study
    • ๐Ÿ“… 2016
    • ๐Ÿ“ˆ Cited by 49
  3. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts
    • ๐Ÿ“… 2017
    • ๐Ÿ“ˆ Cited by 124
  4. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
    • ๐Ÿ“… 2011
    • ๐Ÿ“ˆ Cited by 1611
  5. Smoking, blood cells and myeloproliferative neoplasms: metaโ€analysis and Mendelian randomization of 2ยท 3 million people
    • ๐Ÿ“… 2020
    • ๐Ÿ“ˆ Cited by 37
  6. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’nationwide cohort
    • ๐Ÿ“… 2011
    • ๐Ÿ“ˆ Cited by 601
  7. Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study
    • ๐Ÿ“… 2005
    • ๐Ÿ“ˆ Cited by 359
  8. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study
    • ๐Ÿ“… 2009
    • ๐Ÿ“ˆ Cited by 243
  9. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys
    • ๐Ÿ“… 2015
    • ๐Ÿ“ˆ Cited by 285
  10. Alcohol and cirrhosis: doseโ€“response or threshold effect?
    • ๐Ÿ“… 2004
    • ๐Ÿ“ˆ Cited by 188